SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 10th, 2021 • AzurRx BioPharma, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMarch 10th, 2021 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of March 7, 2021, between AzurRx BioPharma, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
SERIES A COMMON STOCK PURCHASE WARRANT AZURRX BIOPHARMA, INC.Warrant Agreement • March 10th, 2021 • AzurRx BioPharma, Inc. • Pharmaceutical preparations
Contract Type FiledMarch 10th, 2021 Company IndustryTHIS SERIES A COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on March __, 20261 (the “Termination Date”) but not thereafter, to subscribe for and purchase from AzurRx Biopharma, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT AZURRX BIOPHARMA, INC.Placement Agent Common Stock Purchase Warrant • March 10th, 2021 • AzurRx BioPharma, Inc. • Pharmaceutical preparations
Contract Type FiledMarch 10th, 2021 Company IndustryTHIS PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after March 10, 2021 (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on March 7, 2026 (the “Termination Date”) but not thereafter, to subscribe for and purchase from AzurRx BioPharma, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is being issued by the Company pursuant to that certain engagement letter, dated as of October 13, 2020, by and between the Company and H.C. Wainwright & Co., LLC.